Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2008-05-20
2008-05-20
Minnifield, Nita (Department: 1645)
Chemistry: molecular biology and microbiology
Vector, per se
C514S04400A, C424S093100, C424S093200, C424S093600, C536S023100, C536S023700
Reexamination Certificate
active
10405871
ABSTRACT:
Using nucleic acids encoding mutant SEA and SEB exotoxins fromStaphylococcus aureus, compositions and methods for use in inducing an immune response which is protective against staphylococcal aureus intoxication in subjects is described.
REFERENCES:
patent: 5705151 (1998-01-01), Dow et al.
patent: 5789245 (1998-08-01), Dubensky et al.
patent: 5792462 (1998-08-01), Johnston et al.
patent: 5935568 (1999-08-01), Dow et al.
patent: 6015686 (2000-01-01), Dubensky et al.
patent: 6075119 (2000-06-01), Bannan et al.
patent: 6156558 (2000-12-01), Johnston et al.
patent: 6261570 (2001-07-01), Parker et al.
patent: 6296854 (2001-10-01), Pushko et al.
patent: 6399332 (2002-06-01), Ulrich et al.
patent: 6632640 (2003-10-01), Lee et al.
patent: 6984504 (2006-01-01), Hart et al.
patent: 2004/0009183 (2004-01-01), Lee et al.
patent: WO 93/14634 (1993-08-01), None
patent: WO 95/07994 (1995-03-01), None
patent: WO 96/37616 (1996-11-01), None
patent: WO 97/31114 (1997-08-01), None
patent: WO 00/02523 (2000-01-01), None
patent: WO 00/09154 (2000-02-01), None
Marcelle Vianna de Carvalho Uhl et al, Vaccine, 2004, 22:4191-4202.
Hammamieh et al, Biosensors and Bioelectronics, 2004, 20:719-727.
Savransky et al, Toxicon, 2004, 43:433-438.
Lee et al, Advanced Drug Delivery Reviews, 2005, 57:1293-1314.
Lee et al, J. Infectious Diseases, 2002, 185:1192-1196.
Korolev et al, Toxicology, 2003, 187:229-238.
Lowell et al, Infection and Immunity, May 1996, 64/5:1706-0713.
Stiles et al, Infection and Immunity, Apr. 2001, 69/4:2031-2036.
Normanno et al, International J. of Food Microbiology, 2005, 98:73-79.
Ulrich, Army Science Conference: Award Winning Papers, (meeting Jun. 24-27, 1996) ed.:Chait, 1997, pp. 61-66 (abstract only).
Woody et al, J. Infectious Diseases, Apr. 1998, 177/4:1013-1022.
Frolov et al, PNAS, 93:11371-11377.
Clayton et al., “Protective Vaccination with a Recombinant Fragment ofClostridium botulinumNeurotoxin Serotype A Expressed from a Synthetic Gene inE. coli”, Infection and Immunity, Jul. 1995, vol. 63, No. 7, pp. 2738-2742.
Byrne, et al., “Purification, Potency, and Efficacy of the Botulinum Neurotoxin Type A Binding Domain fromPichia pastorisas a Recombinant Vaccine Candidate”, Infection and Immunity, Oct. 1998, vol. 66, No. 10, pp. 4817-4822.
Pushko, et al., “Replicon-Helper Systems from Attenuated Venezuelan Equine Encephalitis Virus: Expression of Heterologous Genes in Vitro and Immunization against Heterologous Pathogens in Vivo,” Virology:239, pp. 389-401 (1997).
Bavari, et al., “Engineered Bacterial Superantigen Vaccines”, Vaccines 96, 1996, pp. 135-141.
Welkos et al., “Sequence and analysis of the DNA encoding protective antigen ofBacillus anthracis”, Gene, 69, 1988, pp. 287-300.
PCT International Search Report for PCT/US 99/15569, mailed Aug. 22, 2000, 13 pages (corresponding foreign application to U.S. Appl. No. 09/350,755).
Bavari et;al., “Superantigen Vaccines: A Comparative Study of Genetically Attenuated REceptor-Binding Mutants ofStaphylococcal enterotoxinA”, Journal of Infectious Diseases, 174:338-345 (1996).
Ulrich et al., “Staphylococcal enterotoxinsA and B share a common structural motif for binding class II major histocompatibiity complex molecules”, Nature Structural Biology, vol 2, No. 6, pp. 554-560, Jun. 1995.
Ulrich et al., “Development of engineered vaccines effective against structurally related bacterial superantigens”, Vaccine, vol. 16, No. 19, pp. 1857-1864 (1998).
Bavari and Ulrich, “Engineered bacterial superantigen vaccines”, Toxicon, vol. 36, pp. 1231-1232 (Sep. 1998) (Abstract).
Nilsson et al., “Protection againstStaphylococcus aureussepsis by vaccination with recombinatnSyaphylcoccal enterotoxinA devoid of superantigenicity”, J. Infectious Diseases, vol. 180, Oct. 1999, pp. 1370-1373.
Krauss et al., J. Hematotherapy 6:41-51 (1997).
Borst et al., Infection & Immunity, vol. 61, No. 12, pp. 5421-5425.
Betley et al., J. Bacteriol., vol. 170, No. 1, pp. 34-41 (1988).
Gidlof et al., Blood, vol. 89, No. 6, pp. 2089-2097 (1997).
Ulrich, FEMS Immunology and Medical Microbiology, 27:1-7 (2000).
Lee et al., Infection and Immunity, vol. 69, No. 9, pp. 5709-5715 (2001).
Kodama et al., Cancer Immunol. Immunother., vol. 50, pp. 539-548 (2001).
Devos et al., Nucleic Acid Research, vol. 10, No. 8, pp. 2487-2501 (1982).
Renaud et al., Epidemiology & Infection, vol. 112, No. 3, pp. 501-511 (1994).
Woody et al., J. Infectious Disease, 177:1013-1022 (1998).
Mahana et al., Infection & Immunity, vol. 63, No. 8, pp. 2826-2832 (1995).
Harris et al., Infection & Immunity, May 1993, vol. 61, No. 5, pp. 2059-2068.
Couch et al., J. Bacteriology, Jul. 1988, vol. 170, No. 7, pp. 2954-2960.
Metzroth et al., Infection and Immunity, vol. 61, No. 6, pp. 2445-2452 (1993).
Ranelli et al., PNAS, 82:5850-5854 (1985).
Dohlsten et al., PNAS 91:8945-8949 (1994).
Buelow et al., J. Immunol., vol. 148, No. 1, pp. 1-6 (1992).
Romanos, et al., “Expression of tetanus toxin fragment C in yeast: gene synthesis is required to eliminate fortuitous polyadenylation sites in AT-rich DNA”, Nucleic Acids Research, vol. 19, No. 7, 1991 , pp. 1461-1467.
Makoff et al., “Expression of tetanus toxin fragment C inE. coli: high level expression by removing rare codons”, Nucleic Acids Research, vol. 17, No. 24, 1989, pp. 10191-10203.
Lee John S.
Pushko Peter
Smith Jonathan F.
Ulrich Robert G.
Arwine Elizabeth
Minnifield Nita
The United States of America as represented by the Secretary of
LandOfFree
Vaccine against staphylococcus intoxication does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine against staphylococcus intoxication, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine against staphylococcus intoxication will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3947711